Fowler CJ - Search Results

1

Targeting the endocannabinoid system for the treatment of cancer--a practical view.

Fowler CJ, Gustafsson SB, Chung SC, Persson E, Jacobsson SO, Bergh A. Fowler CJ, et al. Curr Top Med Chem. 2010;10(8):814-27. doi: 10.2174/156802610791164201. Curr Top Med Chem. 2010. PMID: 20370711 Review.

2

The endocannabinoid signaling system: pharmacological and therapeutic aspects.

Fowler CJ, Holt S, Nilsson O, Jonsson KO, Tiger G, Jacobsson SO. Fowler CJ, et al. Pharmacol Biochem Behav. 2005 Jun;81(2):248-62. doi: 10.1016/j.pbb.2005.01.023. Pharmacol Biochem Behav. 2005. PMID: 15935456 Review.

3

Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development?

Fowler CJ, Jacobsson SO. Fowler CJ, et al. Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):193-200. doi: 10.1054/plef.2001.0357. Prostaglandins Leukot Essent Fatty Acids. 2002. PMID: 12052035 Review.

4

AM404 and VDM 11 non-specifically inhibit C6 glioma cell proliferation at concentrations used to block the cellular accumulation of the endocannabinoid anandamide.

Jonsson KO, Andersson A, Jacobsson SO, Vandevoorde S, Lambert DM, Fowler CJ. Jonsson KO, et al. Among authors: fowler cj. Arch Toxicol. 2003 Apr;77(4):201-7. doi: 10.1007/s00204-002-0435-6. Epub 2003 Feb 25. Arch Toxicol. 2003. PMID: 12698235

5

Cannabinoid CB1 receptor activation does not prevent the toxicity of glutamate towards embryonic chick telencephalon primary cultures.

Nilsson O, Jacobsson SO, Fowler CJ. Nilsson O, et al. Among authors: fowler cj. Comp Biochem Physiol C Toxicol Pharmacol. 2003 Nov;136(3):245-51. doi: 10.1016/s1532-0456(03)00228-x. Comp Biochem Physiol C Toxicol Pharmacol. 2003. PMID: 14659458

6

The cannabinoid CB2 receptor selective agonist JWH133 reduces mast cell oedema in response to compound 48/80 in vivo but not the release of beta-hexosaminidase from skin slices in vitro.

Jonsson KO, Persson E, Fowler CJ. Jonsson KO, et al. Among authors: fowler cj. Life Sci. 2006 Jan 2;78(6):598-606. doi: 10.1016/j.lfs.2005.05.059. Epub 2005 Aug 19. Life Sci. 2006. PMID: 16111718

7

Acyl-based anandamide uptake inhibitors cause rapid toxicity to C6 glioma cells at pharmacologically relevant concentrations.

De Lago E, Gustafsson SB, Fernández-Ruiz J, Nilsson J, Jacobsson SO, Fowler CJ. De Lago E, et al. Among authors: fowler cj. J Neurochem. 2006 Oct;99(2):677-88. doi: 10.1111/j.1471-4159.2006.04104.x. Epub 2006 Aug 8. J Neurochem. 2006. PMID: 16899063 Free article.

8

The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells.

Nilsson O, Fowler CJ, Jacobsson SO. Nilsson O, et al. Among authors: fowler cj. Eur J Pharmacol. 2006 Oct 10;547(1-3):165-73. doi: 10.1016/j.ejphar.2006.07.016. Epub 2006 Jul 22. Eur J Pharmacol. 2006. PMID: 16928371

9

Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4.

Thors L, Bergh A, Persson E, Hammarsten P, Stattin P, Egevad L, Granfors T, Fowler CJ. Thors L, et al. Among authors: fowler cj. PLoS One. 2010 Aug 19;5(8):e12275. doi: 10.1371/journal.pone.0012275. PLoS One. 2010. PMID: 20808855 Free PMC article.

10

Tumour Cannabinoid CB(1) receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancer.

Fowler CJ, Hammarsten P, Bergh A. Fowler CJ, et al. PLoS One. 2010 Dec 23;5(12):e15205. doi: 10.1371/journal.pone.0015205. PLoS One. 2010. PMID: 21203460 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

601 results

Search Page

Filters